UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 282

Sortiert nach

Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated

The American journal of gastroenterology, 1999-07, Vol.94 (7), p.1834-1840

1999

Volltextzugriff (PDF)

How drugs are developed and approved by the FDA: current process and future directions

The American journal of gastroenterology, 2014-05, Vol.109 (5), p.620-623

2014

Volltextzugriff (PDF)

Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells

Cell death & disease, 2014-12, Vol.5 (12), p.e1548-e1548

2014

Volltextzugriff (PDF)

Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth

Oncogene, 2007-10, Vol.26 (46), p.6619-6629

2007

Volltextzugriff (PDF)

Measurement of meal-stimulated gastric acid secretion by in vivo gastric autotitration

Journal of applied physiology (1985), 2002-02, Vol.92 (2), p.427-434

2002

Volltextzugriff (PDF)

A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn

Alimentary pharmacology & therapeutics, 2004-11, Vol.20 (9), p.975-982

2004

Volltextzugriff (PDF)

The FDA's Generic-Drug Approval Process: Similarities to and Differences From Brand-Name Drugs

The American journal of gastroenterology, 2011-06, Vol.106 (6), p.1018-1021

2011

Volltextzugriff (PDF)

Biosimilars: the need, the challenge, the future: the FDA perspective

The American journal of gastroenterology, 2014-12, Vol.109 (12), p.1856-1859

2014

Volltextzugriff (PDF)

The Food and Drug Administration advisory committees and panels: how they are applied to the drug regulatory process

The American journal of gastroenterology, 2014-10, Vol.109 (10), p.1508-1512

2014

Volltextzugriff (PDF)

How Drugs are Developed and Approved by the FDA: Current Process and Future Directions

The American journal of gastroenterology, 2014-05, Vol.109 (5), p.620-623

2014

Volltextzugriff (PDF)

mTOR intersects antibody-inducing signals from TACI in marginal zone B cells

Nature communications, 2017-11, Vol.8 (1), p.1462-16, Article 1462

2017

Volltextzugriff (PDF)

Ranitidine, 75 mg, over‐the‐counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro‐oesophageal reflux

Alimentary pharmacology & therapeutics, 2002-05, Vol.16 (5), p.899-907

2002

Volltextzugriff (PDF)

Promoting healthy teenage behaviour across three European countries through the use of a novel smartphone technology platform, PEGASO fit for future: study protocol of a quasi-experimental, controlled, multi-Centre trial

BMC medical informatics and decision making, 2019-12, Vol.19 (1), p.278-13, Article 278

2019

Volltextzugriff (PDF)

Response to Dr Lewis

The American journal of gastroenterology, 2012-08, Vol.107 (8), p.1264-1265

2012

Volltextzugriff (PDF)

A Warping Strategy and MPME Algorithm for Data Reduction in Near-field Antenna Measurements

2023 Photonics & Electromagnetics Research Symposium (PIERS), 2023, p.338-344

Ciociola, A.

2023

Volltextzugriff (PDF)

Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburn

Alimentary pharmacology & therapeutics, 2002-03, Vol.16 (3), p.435-443

2002

Volltextzugriff (PDF)

Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells : Steroid antagonist action

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (22), p.10585-10593

2005

Volltextzugriff (PDF)

Determination of the time of onset of action of ranitidine and famotidine on intra‐gastric acidity

Alimentary pharmacology & therapeutics, 2002-07, Vol.16 (7), p.1317-1326

2002

Volltextzugriff (PDF)

How the FDA Manages Drug Safety With Black Box Warnings, Use Restrictions, and Drug Removal, With Attention to Gastrointestinal Medications

The American journal of gastroenterology, 2012-04, Vol.107 (4), p.501-504

2012

Volltextzugriff (PDF)

Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence

Alimentary pharmacology & therapeutics, 1996-06, Vol.10 (3), p.251-262

1996

Volltextzugriff (PDF)

Low‐dose ranitidine for the relief of heartburn

Alimentary pharmacology & therapeutics, 1999-04, Vol.13 (4), p.459-465

1999

Volltextzugriff (PDF)

A double‐blind, placebo‐controlled study of the efficacy and safety of non‐prescription ranitidine 75 mg in the prevention of meal‐induced heartburn

Alimentary pharmacology & therapeutics, 1999-04, Vol.13 (4), p.467-473

1999

Volltextzugriff (PDF)

Control of nocturnal gastric acidity: A role for low dose bedtime ranitidine to supplement daily omeprazole

Digestive diseases and sciences, 2002-02, Vol.47 (2), p.265-273

2002

Volltextzugriff (PDF)

GR 38032F (Ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man

Digestive diseases and sciences, 1990-04, Vol.35 (4), p.477-480

1990

Volltextzugriff (PDF)

Prevention of moderate-to-severe meal-induced heartburn: ranitidine 150mg is superior to ranitidine 75mg when taken immediately before the meal

The American journal of gastroenterology, 2002-09, Vol.97 (9), p.S4-S4

2002

Volltextzugriff (PDF)

1 – 25 von 282

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(215)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated

How drugs are developed and approved by the FDA: current process and future directions

Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells

Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth

Measurement of meal-stimulated gastric acid secretion by in vivo gastric autotitration

A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn

The FDA's Generic-Drug Approval Process: Similarities to and Differences From Brand-Name Drugs

Biosimilars: the need, the challenge, the future: the FDA perspective

The Food and Drug Administration advisory committees and panels: how they are applied to the drug regulatory process

How Drugs are Developed and Approved by the FDA: Current Process and Future Directions

mTOR intersects antibody-inducing signals from TACI in marginal zone B cells

Ranitidine, 75 mg, over‐the‐counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro‐oesophageal reflux

Promoting healthy teenage behaviour across three European countries through the use of a novel smartphone technology platform, PEGASO fit for future: study protocol of a quasi-experimental, controlled, multi-Centre trial

Response to Dr Lewis

A Warping Strategy and MPME Algorithm for Data Reduction in Near-field Antenna Measurements

Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburn

Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells : Steroid antagonist action

Determination of the time of onset of action of ranitidine and famotidine on intra‐gastric acidity

How the FDA Manages Drug Safety With Black Box Warnings, Use Restrictions, and Drug Removal, With Attention to Gastrointestinal Medications

Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence

Low‐dose ranitidine for the relief of heartburn

A double‐blind, placebo‐controlled study of the efficacy and safety of non‐prescription ranitidine 75 mg in the prevention of meal‐induced heartburn

Control of nocturnal gastric acidity: A role for low dose bedtime ranitidine to supplement daily omeprazole

GR 38032F (Ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man

Prevention of moderate-to-severe meal-induced heartburn: ranitidine 150mg is superior to ranitidine 75mg when taken immediately before the meal

Suchergebnisse filtern